Far-UVC Light for Respiratory Infections
(PRiVII Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Far-UVC Light for respiratory infections?
Research shows that Far-UVC light at 222 nm can effectively inactivate airborne pathogens like viruses and bacteria, including those causing respiratory infections such as influenza and SARS-CoV-2, without harming human skin or eyes. This makes it a promising tool for reducing the spread of airborne diseases in indoor spaces.12345
Is Far-UVC light safe for humans?
Far-UVC light, with wavelengths between 200 and 235 nm, is considered safe for humans because it cannot penetrate the outer layers of skin or eyes, unlike conventional UV light. Studies have shown that it can be used in occupied spaces without harm, as the doses used are significantly below recommended safe exposure limits.14567
How does far-UVC light treatment differ from other treatments for respiratory infections?
Far-UVC light treatment is unique because it uses a specific wavelength of ultraviolet light (222 nm) to inactivate airborne pathogens safely without harming human skin or eyes. Unlike conventional UVC light, which can be harmful, far-UVC light can be used in occupied indoor spaces to reduce the spread of respiratory infections like influenza and SARS-CoV-2.12348
What is the purpose of this trial?
Elderly people who have multiple health problems are at higher risk of illness from viral respiratory infections, such as influenza (the flu) and COVID-19. This is especially true for residents in long-term care because the usual methods of infection control (handwashing, mask-wearing, and distancing) are difficult to enforce due to the memory problems of many residents and the frequently shared common spaces. It can also be difficult to prevent the spread of viral infections within long-term care because many residents are unable to tell their caregivers when they are feeling ill. Also, some elderly people do not show typical symptoms of infection (like fever), instead they may suddenly become confused or weak.This study will test if a safe form of ultraviolet light (far-UVC) can be effective as an extra method of disinfection (in addition to usual manual cleaning) against airborne and surface viruses that can cause respiratory infections.
Research Team
Kenneth Rockwood, MD
Principal Investigator
Nova Scotia Health Authority
Eligibility Criteria
This trial is for elderly residents in long-term care facilities who are at higher risk of respiratory viral infections like the flu and COVID-19. Participants must consent to join the study, which aims to test additional disinfection methods.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Far-UVC light is used as an additional method of disinfection in common areas of long-term care facilities
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Far-UVC Light
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kenneth Rockwood
Lead Sponsor
Nova Scotia Health Authority
Collaborator
Department of Health, Nova Scotia
Collaborator
Research Nova Scotia
Collaborator